» Articles » PMID: 7465739

Type A Behavior, Hostility, and Coronary Atherosclerosis

Overview
Journal Psychosom Med
Specialty Psychiatry
Date 1980 Nov 1
PMID 7465739
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Type A behavior pattern was assessed using the structured interview and hostility level was assessed using a subscale of the Minnesota Multiphase Personality Inventory in 424 patients who underwent diagnostic coronary arteriography for suspected coronary heart disease. In contrast to non-Type A patients, a significantly greater proportion of Type A patients had at least one artery with a clinically significant occlusion of 75% or greater. In addition, only 48% of those patients with very low scores (less than or equal to 10) on the Hostility scale exhibited a significant occlusion; in contrast, patients in all groups scoring higher than 10 on the Hostility scale showed a 70% rate of significant disease. The essential difference between low and high scorers on the Hostility scale appears to consist of an unwillingness on the part of the low scorers to endorse items reflective of the attitude that others are bad, selfish, and exploitive. Multivariate analysis showed that both Type A behavior pattern and Hostility score are independently related to presence of atherosclerosis. In this analysis, however, Hostility score emerged as more related to presence of atherosclerosis than Type A behavior pattern. These findings confirm previous observations of increased coronary atherosclerosis among Type A patients. They suggest further that an attitudinal set reflective of hostility toward people in general is over and above that accounted for by Type A behavior pattern. These findings also suggest that interventions to reduce the contribution of behavioral patterns to coronary disease risk might profitably focus especially closely on reduction of anger and hostility.

Citing Articles

Personality traits and co-occurrence of depressive symptoms and high BMI: a prospective cohort study.

Chen J, Shan R, Wang Y, Zhang X, Xiao W, Liu Z Eur Child Adolesc Psychiatry. 2024; 34(2):729-738.

PMID: 38985335 DOI: 10.1007/s00787-024-02518-3.


Δ-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research.

Pressman P, Wallace Hayes A, Hoeng J, Latino D, Mazurov A, Schlage W J Clin Med. 2024; 13(6).

PMID: 38541766 PMC: 10971680. DOI: 10.3390/jcm13061540.


Psychological factors and cardiac repolarization instability during anger in implantable cardioverter defibrillator patients.

Krantz D, Harris K, Rogers H, Whittaker K, Haigney M, Kop W Ann Noninvasive Electrocardiol. 2021; 26(4):e12848.

PMID: 33813750 PMC: 8293621. DOI: 10.1111/anec.12848.


Stress and Illness: A Role for Specific Emotions.

Levenson R Psychosom Med. 2019; 81(8):720-730.

PMID: 31343581 PMC: 6786949. DOI: 10.1097/PSY.0000000000000736.


Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials.

Thai-Cuarto D, OBrien C, Jimenez R, Liang G, Burke J Drug Saf. 2017; 41(4):429-440.

PMID: 29218680 PMC: 5878201. DOI: 10.1007/s40264-017-0623-1.